Patent · US Active

Substituted 1,4,8-triazaspiro [4,5]decan-2-one compounds

US7951815B2 · kind B2 · utility

12Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2006
Grant dateMay 31, 2011
Priority date
Expiry dateAug 17, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel 1,4,8-triazaspiro[4,5]decan-2-one compounds corresponding to formula Iprocesses for the preparation thereof, related methods of treatment and pharmaceutical formulations containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.